MoneyBall Medicine

Dekel Gelbman and How Machine Learning Is Changing Rare Disease Diagnosis

Episode Summary

Harry's guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare diseases.

Episode Notes

Harry's guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare diseases.

How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: